Sarah Cannon Research Institute
Brandon Jones has extensive experience in reporting and analytics, currently serving as the Director of Reporting & Analytics at Sarah Cannon Research Institute since November 2012. In this role, Brandon leads program managers and technical workstreams to integrate processes and systems that align with strategic organizational goals. Key responsibilities include managing business analysts, overseeing the development of reports and dashboards, and ensuring data credibility across the organization. Prior positions at Sarah Cannon include Senior Manager of Strategy & Transformation and Program Manager, showcasing a consistent focus on strategic execution and data-driven decision-making. Brandon's career began with roles in financial services and administrative support, complemented by a degree in Business Administration from the University of Kentucky.
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.